Latest Information Update: 25 Mar 2008
At a glance
- Originator Daiichi Fine Chemical
- Mechanism of Action Opioid mu receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 25 Mar 2008 Discontinued - Preclinical for Pain in Japan (unspecified route)
- 18 Dec 2003 No development reported - Preclinical for Pain in Japan (unspecified route)
- 30 Mar 2001 New profile